Allicin Improves Endothelium-Dependent Relaxation In Diabetic Rats Through Maintaining Enos Protein Stability

Yuan-Wan Yin,Hong-Xia Ma,Xiao-Hong Tian,Yan-Cheng Xu
2016-01-01
Abstract:Endothelial nitric oxide (NO) synthase (eNOS) dysfunction-mediated endothelium-dependent relaxation impairment has been suggested to be a principal feature of diabetes-related cardiovascular complications. Allicin is one of the most biologically active compounds in garlic and exerts therapeutic potentials in many pathologic conditions. However, the protective effects of Allicin on eNOS expression and endothelium-dependent relaxation in diabetes remain unknown. In the present study, diabetic rats were induced by intravenous injection of streptozotocin and then orally treated with various concentration of Allicin for 4 weeks. EVC-304 endothelial cells were pretreated with Allicin in prior to incubation of high glucose for 48 h. NO production was determined by biochemical and cellular approaches. eNOS expression was analyzed by immunohistochemistry, real-time quantitative PCR and western blot, respectively. We found that Allicin administration suppressed the elevation of blood pressure in diabetic rats. In addition, Allicin remarkably attenuated diabetes-induced the decrease of NO production and eNOS expression, with a concomitant improvement in endothelial-dependent relaxation. Furthermore, rather than affecting eNOS transcriptional activity and mRNA expression, Allicin prolonged eNOS protein half-life and decreased eNOS ubiquitination. Collectively, Allicin restored eNOS expression through inhibition of ubiquitin-mediated eNOS protein degradation in diabetes, suggesting a novel mechanism for Allicin in the treatment for diabetes-related cardiovascular complications.
What problem does this paper attempt to address?